Alzheimer's disease & dementia

Alzheimer's: Nicotinic receptors as a new therapeutic target

Several scientific studies have indicated that nicotine may be beneficial for memory function. Scientists from the Institut Pasteur and the CNRS set out to shed further light on the properties attributed to nicotine - which ...

Health

Impulsive alcoholics likely to die sooner

Alcohol and impulsivity are a dangerous mix: People with current drinking problems and poor impulse control are more likely to die in the next 15 years, a new study suggests. However, they could get by with a little help ...

Oncology & Cancer

Ipilimumab active in advanced melanoma with brain mets

(HealthDay) -- For some patients with advanced melanoma and brain metastases, ipilimumab is active, according to the results of a phase 2 study published online March 27 in The Lancet Oncology.

Health

Concerns over glutathione skin bleaching in the UK

Skin bleaching with the use of glutathione is on the rise, despite the potential ethical issues and adverse side effects associated with the practice, warns a doctor in The BMJ this week.

Neuroscience

Neuron loss in schizophrenia and depression could be prevented

Gamma-aminobutyric acid (GABA) deficits have been implicated in schizophrenia and depression. In schizophrenia, deficits have been particularly well-described for a subtype of GABA neuron, the parvalbumin fast-spiking interneurons. ...

Medical research

Research discovers inhibitor to reverse toxic DUX4 effects

About one in 8,000 people have facioscapulohumeral muscular dystrophy, according to a 2014 study, which is relatively common in the world of genetic diseases. New University of Minnesota Medical School research identifies ...

page 9 from 20